Scientists explore using artificial intelligence to develop antibiotics with fewer side effects

Scientists are exploring artificial intelligence to develop antibiotics with fewer side effects

A new study explores the potential of artificial intelligence (AI) in the development of improvements antibioticswith accurate and efficient prediction models. The use of AI has grown significantly, enabling applications such as content development, email proofreading, and self-driving cars. However, in the new study, the scientists deployed explainable AI (XAI), a branch of AI that provides justification for model judgments, which is increasingly being used by academics to examine predictive AI models.

The findings will be presented at the American Chemical Society (ACS) Fall 2024 Meeting, which will be held from August 18-22. The study was conducted by researchers at the University of Manitoba, Canada.

While XAI can be applied in a variety of contexts, the team used it to develop antibiotics. Despite AI’s near-omnipotent use, many of its models act as “black boxes,” making the decision-making process opaque. This can lead to mistrust, especially in vital domains like drug discovery.

To overcome this problem, the team used XAI to train AI drug discovery models, particularly those that identify potential new antibiotic candidates. Predictive models are essential given the pressing need for efficient antibiotics in the face of increasing resistance.

Hunter Sturm, a graduate student at the University, said: “AI is the way of the future in chemistry and drug discovery. You need someone to lay the groundwork, and I think I’m doing that.” To anticipate biological effects, the scientists fed databases of drug chemicals into an AI model. An XAI model was then used to examine the precise molecular properties behind these predictions.

Interestingly, XAI uncovered elements that human chemists would have missed, such as the fact that the non-core structures of penicillin compounds are more important than the core itself. To test predicted antibiotic compounds, researchers collaborate with microbiology labs to improve AI models by applying XAI’s insights. Rebecca Davis, a chemistry professor at the University of Manitoba in Canada, noted that “AI is very mistrustful.

“However, there is a better chance of this technology being accepted if we can ask AI to explain itself,” he added.

(With inputs from IANS)

Get Latest news Live on Times Now along with breaking news and top headlines from Health and around the world.



Source link

Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.

Leave a Comment